G2GBio

456160· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩30,850-6.09%

2026-10-15

Financials

Valuation Metrics

G2GBio's Market Cap is ₩5130B. At end of 2025 it was ₩1.1T. Ranked #413 of 2,417 in KR market (top 17%), #145 of 1,636 on KOSDAQ (top 9%), #44 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 19%) by Market Cap.

Investment Metrics(as of 2026-10-15)

Metric	Value	Rank
Size
Market Cap	513.02B KRW	KR#413/2,417 Sec#44/231
Revenue	2.22B KRW	KR#2,377/2,417 Sec#213/231
Net Income	-17.58B KRW	KR—/2,417 Sec—/231
Total Assets	235.05B KRW	KR#1,194/2,417 Sec#84/231
Net Assets	139.02B KRW	KR#1,184/2,417 Sec#89/231
Value
P/B	3.69x	KR#2,207/2,417 Sec#186/231
P/S	231.56x	KR#2,401/2,417 Sec#220/231
FCF Yield	-2.77%	KR—/2,417 Sec—/231
Profitability
ROE	-12.65%	KR#1,987/2,417 Sec#151/231
ROA	-7.48%	KR#2,034/2,417 Sec#149/231
Op. Margin	-568.74%	KR#2,364/2,417 Sec#207/231
Revenue Growth	-44.98%	KR#2,275/2,417 Sec#202/231
Financial Health
Debt Ratio	69.08%	KR#1,205/2,417 Sec#146/231
Total Debt	40.82B KRW	KR#1,084/2,417 Sec#75/231
FCF	-14.23B KRW	KR#1,806/2,417 Sec#166/231
Cash	12.07B KRW	KR#1,577/2,417 Sec#132/231
Current Ratio	2.38x	KR#724/2,417 Sec#86/231
Performance
1Y Return	-51.70%	KR#1,891/2,417 Sec#171/231
1M Return	-9.53%	KR#320/2,417 Sec#25/231
From 52W High	-75.12%	KR#2,164/2,417 Sec#187/231
1Y MDD	-80.68%	KR#2,302/2,417 Sec#209/231
Trading
Volume	153,369 shares	KR#478/2,417 Sec#48/231
Trading Value	4.70B KRW	KR#282/2,417 Sec#26/231
Foreign Own.	5.69%	KR#767/2,417 Sec#71/231
Per Share
EPS	-1,057 KRW	KR—/2,417 Sec—/231
BPS	8,360 KRW	KR#1,113/2,417 Sec#78/231